| 项目编号 |
PRJCA010833 |
| 项目标题 |
Molecular profiling of the clinical response of liver cancer patients to combination therapy with anti-PD1 and lenvatinib |
| 涉及领域 |
Medical |
| 数据类型 |
Proteomics, Metabolomics
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Combination therapy using tyrosine kinase inhibitor like Lenvatinib and anti-programmed death-1 receptor (PD1) immunotherapy represents an effective systemic treatment of unresectable hepatocellular carcinoma (uHCC). However, patients' responses vary considerably. The molecular responsiveness of HCC patients deserves to be explored and prediction method of potential responders remains to be investigated. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-07-27 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China (NSFC)
|
|
81572833
|
|
| National Natural Science Foundation of China (NSFC)
|
|
22074020
|
|
| National Natural Science Foundation of China (NSFC)
|
|
81871929
|
|
| National Natural Science Foundation of China (NSFC)
|
|
82072667
|
|
| Chen Guang Program of Shanghai Municipal Education Commission
|
|
19CG07
|
|
| Young Elite Scientists Sponsorship Program by CAST
|
|
2019QNRC001
|
|
|
|
| 提交者 |
Cheng
Huang (huang.cheng@zs-hospital.sh.cn)
|
| 提交单位 |
Zhongshan Hospital, Fudan University |
| 提交日期 |
2022-07-27 |
